

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | purine nucleobase biosynthetic process (GO:0009113) | 4.87691116 |
| 2 | neutrophil activation involved in immune response (GO:0002283) | 4.84426942 |
| 3 | response to peptidoglycan (GO:0032494) | 4.83044866 |
| 4 | DNA deamination (GO:0045006) | 4.64787392 |
| 5 | nucleobase biosynthetic process (GO:0046112) | 4.59325305 |
| 6 | folic acid metabolic process (GO:0046655) | 4.44878419 |
| 7 | immunoglobulin mediated immune response (GO:0016064) | 4.40305966 |
| 8 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.18709028 |
| 9 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.03000498 |
| 10 | negative regulation of cell killing (GO:0031342) | 4.03000498 |
| 11 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.01809316 |
| 12 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.01809316 |
| 13 | modulation by symbiont of host immune response (GO:0052553) | 4.01809316 |
| 14 | positive regulation by symbiont of host defense response (GO:0052509) | 4.01809316 |
| 15 | modulation by symbiont of host defense response (GO:0052031) | 4.01809316 |
| 16 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.01809316 |
| 17 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.97722577 |
| 18 | negative regulation of interleukin-12 production (GO:0032695) | 3.91117081 |
| 19 | regulation of mast cell degranulation (GO:0043304) | 3.80581998 |
| 20 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.80524224 |
| 21 | glycine metabolic process (GO:0006544) | 3.69847676 |
| 22 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.68732604 |
| 23 | respiratory burst (GO:0045730) | 3.53081170 |
| 24 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.51857539 |
| 25 | detection of bacterium (GO:0016045) | 3.51775824 |
| 26 | detection of other organism (GO:0098543) | 3.51253864 |
| 27 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.51174287 |
| 28 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.44964373 |
| 29 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.43509744 |
| 30 | neutrophil activation (GO:0042119) | 3.42005396 |
| 31 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.38247495 |
| 32 | proteasome assembly (GO:0043248) | 3.37072238 |
| 33 | response to host immune response (GO:0052572) | 3.36073762 |
| 34 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.36073762 |
| 35 | NIK/NF-kappaB signaling (GO:0038061) | 3.32895516 |
| 36 | folic acid transport (GO:0015884) | 3.32278297 |
| 37 | regulation of leukocyte degranulation (GO:0043300) | 3.31147639 |
| 38 | DNA replication checkpoint (GO:0000076) | 3.28814336 |
| 39 | granulocyte activation (GO:0036230) | 3.25474907 |
| 40 | positive regulation of mast cell activation (GO:0033005) | 3.25307878 |
| 41 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.24177933 |
| 42 | positive regulation of B cell differentiation (GO:0045579) | 3.23583324 |
| 43 | B cell mediated immunity (GO:0019724) | 3.22855999 |
| 44 | formation of translation preinitiation complex (GO:0001731) | 3.19744373 |
| 45 | L-methionine salvage (GO:0071267) | 3.19368096 |
| 46 | L-methionine biosynthetic process (GO:0071265) | 3.19368096 |
| 47 | amino acid salvage (GO:0043102) | 3.19368096 |
| 48 | response to muramyl dipeptide (GO:0032495) | 3.17592054 |
| 49 | positive regulation of mast cell degranulation (GO:0043306) | 3.15749776 |
| 50 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.15749776 |
| 51 | purine deoxyribonucleotide catabolic process (GO:0009155) | 3.11750926 |
| 52 | macrophage activation involved in immune response (GO:0002281) | 3.11446957 |
| 53 | sulfur amino acid biosynthetic process (GO:0000097) | 3.09811468 |
| 54 | serine family amino acid biosynthetic process (GO:0009070) | 3.07364910 |
| 55 | serine family amino acid catabolic process (GO:0009071) | 3.06335420 |
| 56 | myeloid cell activation involved in immune response (GO:0002275) | 3.05427534 |
| 57 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.03855844 |
| 58 | ribosome biogenesis (GO:0042254) | 3.03277557 |
| 59 | S-adenosylmethionine metabolic process (GO:0046500) | 3.03003914 |
| 60 | deoxyribonucleotide catabolic process (GO:0009264) | 3.01071139 |
| 61 | cellular extravasation (GO:0045123) | 2.98195915 |
| 62 | negative regulation of B cell apoptotic process (GO:0002903) | 2.97809296 |
| 63 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.97535085 |
| 64 | vitamin transmembrane transport (GO:0035461) | 2.96251729 |
| 65 | leukocyte aggregation (GO:0070486) | 2.95849282 |
| 66 | ribosome assembly (GO:0042255) | 2.95535675 |
| 67 | leukocyte degranulation (GO:0043299) | 2.95335245 |
| 68 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.95101240 |
| 69 | regulation of mast cell activation (GO:0033003) | 2.94722270 |
| 70 | methionine biosynthetic process (GO:0009086) | 2.92501778 |
| 71 | regulation of regulated secretory pathway (GO:1903305) | 2.91429861 |
| 72 | deoxyribose phosphate catabolic process (GO:0046386) | 2.91277529 |
| 73 | negative regulation of phagocytosis (GO:0050765) | 2.90689454 |
| 74 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.90391764 |
| 75 | rRNA modification (GO:0000154) | 2.89660413 |
| 76 | response to host (GO:0075136) | 2.88034815 |
| 77 | response to host defenses (GO:0052200) | 2.88034815 |
| 78 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.88034815 |
| 79 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.87681477 |
| 80 | pantothenate metabolic process (GO:0015939) | 2.87384254 |
| 81 | serine family amino acid metabolic process (GO:0009069) | 2.87090719 |
| 82 | cellular metabolic compound salvage (GO:0043094) | 2.85777443 |
| 83 | nucleoside salvage (GO:0043174) | 2.85338320 |
| 84 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.84944475 |
| 85 | actin nucleation (GO:0045010) | 2.84306745 |
| 86 | GDP-mannose metabolic process (GO:0019673) | 2.83327961 |
| 87 | methionine metabolic process (GO:0006555) | 2.83030916 |
| 88 | ribosomal small subunit assembly (GO:0000028) | 2.82806124 |
| 89 | folic acid-containing compound metabolic process (GO:0006760) | 2.82673049 |
| 90 | mitotic metaphase plate congression (GO:0007080) | 2.82488138 |
| 91 | DNA strand elongation (GO:0022616) | 2.81480046 |
| 92 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.81386516 |
| 93 | termination of RNA polymerase III transcription (GO:0006386) | 2.81136398 |
| 94 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.81136398 |
| 95 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.79661675 |
| 96 | modulation by virus of host process (GO:0019054) | 2.74569386 |
| 97 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.74352377 |
| 98 | base-excision repair, AP site formation (GO:0006285) | 2.73695317 |
| 99 | DNA replication initiation (GO:0006270) | 2.72663732 |
| 100 | detection of external biotic stimulus (GO:0098581) | 2.71179795 |
| 101 | protein retention in ER lumen (GO:0006621) | 2.70400864 |
| 102 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.68427363 |
| 103 | Golgi transport vesicle coating (GO:0048200) | 2.67825013 |
| 104 | COPI coating of Golgi vesicle (GO:0048205) | 2.67825013 |
| 105 | L-serine metabolic process (GO:0006563) | 2.66722680 |
| 106 | maturation of SSU-rRNA (GO:0030490) | 2.66305050 |
| 107 | proline biosynthetic process (GO:0006561) | 2.65146439 |
| 108 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.64443630 |
| 109 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.64196245 |
| 110 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.63998610 |
| 111 | positive regulation of release of cytochrome c from mitochondria (GO:0090200) | 2.63110229 |
| 112 | cysteine metabolic process (GO:0006534) | 2.62680120 |
| 113 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.62679021 |
| 114 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.62554976 |
| 115 | positive thymic T cell selection (GO:0045059) | 2.62458154 |
| 116 | neutrophil mediated immunity (GO:0002446) | 2.60599049 |
| 117 | regulation of gamma-delta T cell activation (GO:0046643) | 2.60408391 |
| 118 | pentose metabolic process (GO:0019321) | 2.60058671 |
| 119 | intestinal cholesterol absorption (GO:0030299) | 2.59990004 |
| 120 | negative regulation of innate immune response (GO:0045824) | 2.59378930 |
| 121 | purine nucleotide salvage (GO:0032261) | 2.59053315 |
| 122 | termination of RNA polymerase I transcription (GO:0006363) | 2.58816631 |
| 123 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.58804896 |
| 124 | regulation of defense response to virus by virus (GO:0050690) | 2.57923852 |
| 125 | GMP metabolic process (GO:0046037) | 2.56600008 |
| 126 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.56197938 |
| 127 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.56059500 |
| 128 | homocysteine metabolic process (GO:0050667) | 2.55763700 |
| 129 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.55719233 |
| 130 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.55719233 |
| 131 | positive regulation of protein homooligomerization (GO:0032464) | 2.55308727 |
| 132 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.54706728 |
| 133 | amino sugar catabolic process (GO:0046348) | 2.53048060 |
| 134 | pseudouridine synthesis (GO:0001522) | 2.52009647 |
| 135 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.51424308 |
| 136 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.51317115 |
| 137 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.50975938 |
| 138 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.50503157 |
| 139 | phagosome maturation (GO:0090382) | 2.50363799 |
| 140 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.50178479 |
| 141 | positive regulation of antigen processing and presentation (GO:0002579) | 2.50153410 |
| 142 | pteridine-containing compound metabolic process (GO:0042558) | 2.49860709 |
| 143 | telomere maintenance via recombination (GO:0000722) | 2.49204532 |
| 144 | regulation of T cell tolerance induction (GO:0002664) | 2.48766055 |
| 145 | regulation of antigen processing and presentation (GO:0002577) | 2.48135236 |
| 146 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.47642899 |
| 147 | L-phenylalanine metabolic process (GO:0006558) | 2.47642899 |
| 148 | regulation of B cell apoptotic process (GO:0002902) | 2.47415467 |
| 149 | autophagic vacuole fusion (GO:0000046) | 2.47234941 |
| 150 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.45687872 |
| 151 | regulation of B cell differentiation (GO:0045577) | 2.45528400 |
| 152 | glycosphingolipid catabolic process (GO:0046479) | 2.45507674 |
| 153 | transcription elongation from RNA polymerase I promoter (GO:0006362) | 2.44935349 |
| 154 | defense response to protozoan (GO:0042832) | 2.44419823 |
| 155 | metallo-sulfur cluster assembly (GO:0031163) | 2.44307336 |
| 156 | iron-sulfur cluster assembly (GO:0016226) | 2.44307336 |
| 157 | negative regulation of T cell mediated immunity (GO:0002710) | 2.44241712 |
| 158 | tetrahydrofolate metabolic process (GO:0046653) | 2.43684383 |
| 159 | indole-containing compound catabolic process (GO:0042436) | 2.43540900 |
| 160 | indolalkylamine catabolic process (GO:0046218) | 2.43540900 |
| 161 | tryptophan catabolic process (GO:0006569) | 2.43540900 |
| 162 | positive regulation of regulated secretory pathway (GO:1903307) | 2.42717864 |
| 163 | detection of biotic stimulus (GO:0009595) | 2.42564580 |
| 164 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.42410469 |
| 165 | nucleotide salvage (GO:0043173) | 2.42289840 |
| 166 | transcription from RNA polymerase I promoter (GO:0006360) | 2.41495843 |
| 167 | one-carbon metabolic process (GO:0006730) | 2.41420351 |
| 168 | rRNA methylation (GO:0031167) | 2.40401260 |
| 169 | aspartate family amino acid biosynthetic process (GO:0009067) | 2.39947372 |
| 170 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.39292973 |
| 171 | aromatic amino acid family catabolic process (GO:0009074) | 2.39229045 |
| 172 | rRNA processing (GO:0006364) | 2.38577730 |
| 173 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.38406871 |
| 174 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.38406871 |
| 175 | pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130) | 2.37950352 |
| 176 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.37597661 |
| 177 | 7-methylguanosine mRNA capping (GO:0006370) | 2.36905231 |
| 178 | sulfur amino acid catabolic process (GO:0000098) | 2.36849455 |
| 179 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.36759180 |
| 180 | L-phenylalanine catabolic process (GO:0006559) | 2.36759180 |
| 181 | negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244) | 2.36736596 |
| 182 | negative regulation of DNA-templated transcription, elongation (GO:0032785) | 2.36736596 |
| 183 | pyrimidine nucleoside salvage (GO:0043097) | 2.36184545 |
| 184 | pyrimidine-containing compound salvage (GO:0008655) | 2.36184545 |
| 185 | regulation of translation in response to stress (GO:0043555) | 2.36057981 |
| 186 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.35854597 |
| 187 | peptidyl-histidine modification (GO:0018202) | 2.35379694 |
| 188 | tryptophan metabolic process (GO:0006568) | 2.34196828 |
| 189 | sulfur amino acid metabolic process (GO:0000096) | 2.33672069 |
| 190 | N-acetylneuraminate metabolic process (GO:0006054) | 2.33219233 |
| 191 | ribosomal large subunit biogenesis (GO:0042273) | 2.32666113 |
| 192 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 2.32029976 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.07363187 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.50361934 |
| 3 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.27964563 |
| 4 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.15708862 |
| 5 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.10148122 |
| 6 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.02364128 |
| 7 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.78304546 |
| 8 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.75817975 |
| 9 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.64506269 |
| 10 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.61399947 |
| 11 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.54309378 |
| 12 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.50667949 |
| 13 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.50460149 |
| 14 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.43960433 |
| 15 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.24552171 |
| 16 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.19402974 |
| 17 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.11245211 |
| 18 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.05684427 |
| 19 | * LXR_22292898_ChIP-Seq_THP-1_Human | 2.04989773 |
| 20 | * VDR_23849224_ChIP-Seq_CD4+_Human | 2.03386327 |
| 21 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.02924720 |
| 22 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.00327144 |
| 23 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.00029186 |
| 24 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.95050986 |
| 25 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.93603823 |
| 26 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.89551345 |
| 27 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.88365369 |
| 28 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.87409193 |
| 29 | * XRN2_22483619_ChIP-Seq_HELA_Human | 1.86839860 |
| 30 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.85563569 |
| 31 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.84280781 |
| 32 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.83650717 |
| 33 | UTX_26944678_Chip-Seq_JUKART_Human | 1.83629056 |
| 34 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.83024404 |
| 35 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.81554547 |
| 36 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.81421441 |
| 37 | MAF_26560356_Chip-Seq_TH1_Human | 1.80916994 |
| 38 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.79731509 |
| 39 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.79718686 |
| 40 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.78755799 |
| 41 | MAF_26560356_Chip-Seq_TH2_Human | 1.73470576 |
| 42 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.73036809 |
| 43 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.73020807 |
| 44 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.72905063 |
| 45 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.72708846 |
| 46 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.69061613 |
| 47 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.68154385 |
| 48 | MYC_22102868_ChIP-Seq_BL_Human | 1.66731301 |
| 49 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.65332230 |
| 50 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.64723584 |
| 51 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.61349927 |
| 52 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.60253295 |
| 53 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.59211710 |
| 54 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.59053022 |
| 55 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.58752826 |
| 56 | * P68_20966046_ChIP-Seq_HELA_Human | 1.58746154 |
| 57 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.58246680 |
| 58 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.57332813 |
| 59 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.55349718 |
| 60 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.54728381 |
| 61 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.54158508 |
| 62 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.53972800 |
| 63 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.53372516 |
| 64 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.52726519 |
| 65 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.48053528 |
| 66 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.47967465 |
| 67 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.47336697 |
| 68 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.46807130 |
| 69 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.44523257 |
| 70 | * THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.44317732 |
| 71 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.44041936 |
| 72 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.43031182 |
| 73 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.42106205 |
| 74 | SPI1_23127762_ChIP-Seq_K562_Human | 1.41464117 |
| 75 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.41308029 |
| 76 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.41304981 |
| 77 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.41148419 |
| 78 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.40564693 |
| 79 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.40514418 |
| 80 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.37838236 |
| 81 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.37611739 |
| 82 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.37377522 |
| 83 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.36607991 |
| 84 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.36594231 |
| 85 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.36271325 |
| 86 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.35032011 |
| 87 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.34123747 |
| 88 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.32717213 |
| 89 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.32405728 |
| 90 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.30518035 |
| 91 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.29810851 |
| 92 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.29267782 |
| 93 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.28669233 |
| 94 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.28504789 |
| 95 | * TTF2_22483619_ChIP-Seq_HELA_Human | 1.27587152 |
| 96 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.26849951 |
| 97 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.26368170 |
| 98 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.26217822 |
| 99 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.25719137 |
| 100 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.25586344 |
| 101 | * CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.25289938 |
| 102 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.24923137 |
| 103 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.22355008 |
| 104 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.21578239 |
| 105 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21491615 |
| 106 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.19703032 |
| 107 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.18994904 |
| 108 | * PHF8_20622854_ChIP-Seq_HELA_Human | 1.18530211 |
| 109 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.18215549 |
| 110 | MYB_26560356_Chip-Seq_TH2_Human | 1.18170796 |
| 111 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.17698406 |
| 112 | * CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.15898433 |
| 113 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.15887747 |
| 114 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.15329629 |
| 115 | * E2F1_20622854_ChIP-Seq_HELA_Human | 1.14688626 |
| 116 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.13889721 |
| 117 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.13605548 |
| 118 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.11068455 |
| 119 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.10858126 |
| 120 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.10830086 |
| 121 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.10696786 |
| 122 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.10396681 |
| 123 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.10372515 |
| 124 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.10304014 |
| 125 | MYB_26560356_Chip-Seq_TH1_Human | 1.10180619 |
| 126 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.09099377 |
| 127 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.08781305 |
| 128 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.08333646 |
| 129 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.08172286 |
| 130 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.08143615 |
| 131 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.06737918 |
| 132 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.05530533 |
| 133 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.04873369 |
| 134 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.04709989 |
| 135 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.04573207 |
| 136 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03385263 |
| 137 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.02202661 |
| 138 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.01863861 |
| 139 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.00026163 |
| 140 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.98601130 |
| 141 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96952250 |
| 142 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.96539263 |
| 143 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.96102779 |
| 144 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.95875311 |
| 145 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.95608418 |
| 146 | * POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.94839771 |
| 147 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.94237646 |
| 148 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.93230591 |
| 149 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.91398385 |
| 150 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.91009741 |
| 151 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.90170895 |
| 152 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.88059892 |
| 153 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.86547981 |
| 154 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.84045164 |
| 155 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.83253062 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003693_abnormal_embryo_hatching | 4.11114945 |
| 2 | MP0005365_abnormal_bile_salt | 3.44640574 |
| 3 | MP0002139_abnormal_hepatobiliary_system | 3.33822045 |
| 4 | MP0009840_abnormal_foam_cell | 3.33053492 |
| 5 | MP0003303_peritoneal_inflammation | 3.32754130 |
| 6 | MP0005360_urolithiasis | 2.69817857 |
| 7 | MP0009278_abnormal_bone_marrow | 2.69423431 |
| 8 | MP0005085_abnormal_gallbladder_physiolo | 2.55999317 |
| 9 | MP0003172_abnormal_lysosome_physiology | 2.48110135 |
| 10 | MP0003806_abnormal_nucleotide_metabolis | 2.40127276 |
| 11 | MP0003111_abnormal_nucleus_morphology | 2.36339997 |
| 12 | MP0001666_abnormal_nutrient_absorption | 2.25776311 |
| 13 | MP0004957_abnormal_blastocyst_morpholog | 2.09680730 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.05978885 |
| 15 | MP0003718_maternal_effect | 1.94927649 |
| 16 | MP0009333_abnormal_splenocyte_physiolog | 1.94708510 |
| 17 | MP0010094_abnormal_chromosome_stability | 1.92956229 |
| 18 | MP0003077_abnormal_cell_cycle | 1.92000652 |
| 19 | MP0008875_abnormal_xenobiotic_pharmacok | 1.91023708 |
| 20 | MP0003183_abnormal_peptide_metabolism | 1.89721007 |
| 21 | MP0002132_abnormal_respiratory_system | 1.88612600 |
| 22 | MP0009764_decreased_sensitivity_to | 1.85220651 |
| 23 | MP0001533_abnormal_skeleton_physiology | 1.82146204 |
| 24 | MP0005451_abnormal_body_composition | 1.79626555 |
| 25 | MP0004019_abnormal_vitamin_homeostasis | 1.79375951 |
| 26 | MP0008058_abnormal_DNA_repair | 1.78596988 |
| 27 | MP0005220_abnormal_exocrine_pancreas | 1.76470534 |
| 28 | MP0002653_abnormal_ependyma_morphology | 1.74174958 |
| 29 | MP0000490_abnormal_crypts_of | 1.73142330 |
| 30 | MP0008007_abnormal_cellular_replicative | 1.71202573 |
| 31 | MP0003252_abnormal_bile_duct | 1.70269115 |
| 32 | MP0010329_abnormal_lipoprotein_level | 1.65759888 |
| 33 | MP0001835_abnormal_antigen_presentation | 1.63683519 |
| 34 | MP0005083_abnormal_biliary_tract | 1.62653068 |
| 35 | MP0000465_gastrointestinal_hemorrhage | 1.61480623 |
| 36 | MP0002396_abnormal_hematopoietic_system | 1.56563071 |
| 37 | MP0003186_abnormal_redox_activity | 1.52262458 |
| 38 | MP0005332_abnormal_amino_acid | 1.50503019 |
| 39 | MP0001764_abnormal_homeostasis | 1.47799283 |
| 40 | MP0000609_abnormal_liver_physiology | 1.46269446 |
| 41 | MP0003866_abnormal_defecation | 1.44547813 |
| 42 | MP0005084_abnormal_gallbladder_morpholo | 1.44255270 |
| 43 | MP0003300_gastrointestinal_ulcer | 1.43503932 |
| 44 | MP0005671_abnormal_response_to | 1.43388608 |
| 45 | MP0003763_abnormal_thymus_physiology | 1.41718769 |
| 46 | MP0003436_decreased_susceptibility_to | 1.40918823 |
| 47 | MP0005058_abnormal_lysosome_morphology | 1.39868537 |
| 48 | MP0003724_increased_susceptibility_to | 1.34944366 |
| 49 | MP0002822_catalepsy | 1.31351320 |
| 50 | MP0005319_abnormal_enzyme/_coenzyme | 1.30301002 |
| 51 | MP0009643_abnormal_urine_homeostasis | 1.29147424 |
| 52 | MP0004264_abnormal_extraembryonic_tissu | 1.28760123 |
| 53 | MP0009785_altered_susceptibility_to | 1.27775082 |
| 54 | MP0008260_abnormal_autophagy | 1.26104513 |
| 55 | MP0000685_abnormal_immune_system | 1.23472199 |
| 56 | MP0003075_altered_response_to | 1.23404271 |
| 57 | MP0006082_CNS_inflammation | 1.19484048 |
| 58 | MP0008469_abnormal_protein_level | 1.18786969 |
| 59 | MP0001853_heart_inflammation | 1.16758775 |
| 60 | MP0001800_abnormal_humoral_immune | 1.16255614 |
| 61 | MP0000689_abnormal_spleen_morphology | 1.16098796 |
| 62 | MP0000343_altered_response_to | 1.16021433 |
| 63 | MP0004510_myositis | 1.15514806 |
| 64 | MP0002138_abnormal_hepatobiliary_system | 1.14207847 |
| 65 | MP0005464_abnormal_platelet_physiology | 1.13894455 |
| 66 | MP0002398_abnormal_bone_marrow | 1.13824911 |
| 67 | MP0000598_abnormal_liver_morphology | 1.13567973 |
| 68 | MP0002722_abnormal_immune_system | 1.13495085 |
| 69 | MP0005025_abnormal_response_to | 1.10845875 |
| 70 | MP0003786_premature_aging | 1.10399241 |
| 71 | MP0001845_abnormal_inflammatory_respons | 1.07896747 |
| 72 | MP0003195_calcinosis | 1.07787557 |
| 73 | MP0002277_abnormal_respiratory_mucosa | 1.07654031 |
| 74 | MP0000858_altered_metastatic_potential | 1.07141270 |
| 75 | MP0002723_abnormal_immune_serum | 1.06893808 |
| 76 | MP0005075_abnormal_melanosome_morpholog | 1.06111768 |
| 77 | MP0010155_abnormal_intestine_physiology | 1.05008569 |
| 78 | MP0002452_abnormal_antigen_presenting | 1.04891703 |
| 79 | MP0005000_abnormal_immune_tolerance | 1.03593889 |
| 80 | MP0001819_abnormal_immune_cell | 1.03064999 |
| 81 | MP0002420_abnormal_adaptive_immunity | 1.02756129 |
| 82 | MP0004808_abnormal_hematopoietic_stem | 1.02746742 |
| 83 | MP0009765_abnormal_xenobiotic_induced | 1.02724854 |
| 84 | MP0006054_spinal_hemorrhage | 1.02160683 |
| 85 | MP0002148_abnormal_hypersensitivity_rea | 1.02108304 |
| 86 | MP0002429_abnormal_blood_cell | 1.01452100 |
| 87 | MP0000716_abnormal_immune_system | 0.99903706 |
| 88 | MP0000604_amyloidosis | 0.99410241 |
| 89 | MP0002419_abnormal_innate_immunity | 0.98133794 |
| 90 | MP0001727_abnormal_embryo_implantation | 0.97299044 |
| 91 | MP0010307_abnormal_tumor_latency | 0.96979216 |
| 92 | MP0006035_abnormal_mitochondrial_morpho | 0.96805472 |
| 93 | MP0002019_abnormal_tumor_incidence | 0.96771373 |
| 94 | MP0008057_abnormal_DNA_replication | 0.96703948 |
| 95 | MP0001730_embryonic_growth_arrest | 0.94296549 |
| 96 | MP0003868_abnormal_feces_composition | 0.93631365 |
| 97 | MP0005397_hematopoietic_system_phenotyp | 0.93613736 |
| 98 | MP0001545_abnormal_hematopoietic_system | 0.93613736 |
| 99 | MP0005410_abnormal_fertilization | 0.91532748 |
| 100 | MP0001756_abnormal_urination | 0.90099115 |
| 101 | MP0005636_abnormal_mineral_homeostasis | 0.89685092 |
| 102 | MP0001663_abnormal_digestive_system | 0.89541180 |
| 103 | MP0001873_stomach_inflammation | 0.89043870 |
| 104 | MP0009763_increased_sensitivity_to | 0.88716682 |
| 105 | MP0003828_pulmonary_edema | 0.86251887 |
| 106 | MP0003878_abnormal_ear_physiology | 0.85851750 |
| 107 | MP0005377_hearing/vestibular/ear_phenot | 0.85851750 |
| 108 | MP0000703_abnormal_thymus_morphology | 0.85851521 |
| 109 | MP0006036_abnormal_mitochondrial_physio | 0.85746166 |
| 110 | MP0002118_abnormal_lipid_homeostasis | 0.85316133 |
| 111 | MP0002405_respiratory_system_inflammati | 0.85201127 |
| 112 | MP0008932_abnormal_embryonic_tissue | 0.84218681 |
| 113 | MP0003656_abnormal_erythrocyte_physiolo | 0.83550830 |
| 114 | MP0002693_abnormal_pancreas_physiology | 0.83358442 |
| 115 | MP0000313_abnormal_cell_death | 0.82946118 |
| 116 | MP0005310_abnormal_salivary_gland | 0.80743778 |
| 117 | MP0005395_other_phenotype | 0.80712948 |
| 118 | MP0000350_abnormal_cell_proliferation | 0.80473319 |
| 119 | MP0002998_abnormal_bone_remodeling | 0.80137240 |
| 120 | MP0002136_abnormal_kidney_physiology | 0.79731487 |
| 121 | MP0005387_immune_system_phenotype | 0.79518679 |
| 122 | MP0001790_abnormal_immune_system | 0.79518679 |
| 123 | MP0004947_skin_inflammation | 0.79384525 |
| 124 | MP0001661_extended_life_span | 0.77376891 |
| 125 | MP0001986_abnormal_taste_sensitivity | 0.76664858 |
| 126 | MP0000358_abnormal_cell_content/ | 0.76236801 |
| 127 | MP0001944_abnormal_pancreas_morphology | 0.76055072 |
| 128 | MP0005390_skeleton_phenotype | 0.73511139 |
| 129 | MP0000678_abnormal_parathyroid_gland | 0.72747450 |
| 130 | MP0008874_decreased_physiological_sensi | 0.70362831 |
| 131 | MP0005166_decreased_susceptibility_to | 0.67993187 |
| 132 | MP0004381_abnormal_hair_follicle | 0.67663123 |
| 133 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.67024796 |
| 134 | MP0000681_abnormal_thyroid_gland | 0.65091523 |
| 135 | MP0001849_ear_inflammation | 0.64173298 |
| 136 | MP0003329_amyloid_beta_deposits | 0.63972839 |
| 137 | MP0001851_eye_inflammation | 0.63032905 |
| 138 | MP0003221_abnormal_cardiomyocyte_apopto | 0.60238034 |
| 139 | MP0003448_altered_tumor_morphology | 0.59708100 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 4.85612221 |
| 2 | Abnormality of glycolipid metabolism (HP:0010969) | 4.67876204 |
| 3 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.67876204 |
| 4 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.67876204 |
| 5 | Recurrent bacterial skin infections (HP:0005406) | 4.67176845 |
| 6 | Abnormality of macrophages (HP:0004311) | 4.65781033 |
| 7 | Obstructive lung disease (HP:0006536) | 4.51771328 |
| 8 | Chronic obstructive pulmonary disease (HP:0006510) | 4.51771328 |
| 9 | Eczematoid dermatitis (HP:0000976) | 4.43094812 |
| 10 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.16774919 |
| 11 | Myositis (HP:0100614) | 3.76284487 |
| 12 | Mediastinal lymphadenopathy (HP:0100721) | 3.73295675 |
| 13 | Hyperglycinemia (HP:0002154) | 3.66390535 |
| 14 | Hyperglycinuria (HP:0003108) | 3.59900411 |
| 15 | Birth length less than 3rd percentile (HP:0003561) | 3.48759192 |
| 16 | Increased IgM level (HP:0003496) | 3.39926574 |
| 17 | Stomatitis (HP:0010280) | 3.39136531 |
| 18 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.32580057 |
| 19 | Increased cerebral lipofuscin (HP:0011813) | 3.31592143 |
| 20 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.23786979 |
| 21 | Meningitis (HP:0001287) | 3.16827618 |
| 22 | Recurrent fungal infections (HP:0002841) | 3.14211685 |
| 23 | Breast hypoplasia (HP:0003187) | 3.05232430 |
| 24 | Reduced antithrombin III activity (HP:0001976) | 3.00286721 |
| 25 | Microretrognathia (HP:0000308) | 3.00212270 |
| 26 | Orchitis (HP:0100796) | 2.98461980 |
| 27 | Purpura (HP:0000979) | 2.92210783 |
| 28 | Recurrent skin infections (HP:0001581) | 2.92130267 |
| 29 | Urticaria (HP:0001025) | 2.90695080 |
| 30 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.87127325 |
| 31 | Abnormality of glycine metabolism (HP:0010895) | 2.87127325 |
| 32 | Dysostosis multiplex (HP:0000943) | 2.86358166 |
| 33 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.84241433 |
| 34 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.84006860 |
| 35 | Hypobetalipoproteinemia (HP:0003563) | 2.82605214 |
| 36 | Increased IgE level (HP:0003212) | 2.81869797 |
| 37 | Increased serum ferritin (HP:0003281) | 2.80850184 |
| 38 | Loss of speech (HP:0002371) | 2.79599645 |
| 39 | Hypertensive crisis (HP:0100735) | 2.75805663 |
| 40 | Vacuolated lymphocytes (HP:0001922) | 2.75184998 |
| 41 | Gout (HP:0001997) | 2.73905846 |
| 42 | Recurrent viral infections (HP:0004429) | 2.70680900 |
| 43 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.70533309 |
| 44 | Abnormality of serum amino acid levels (HP:0003112) | 2.68704041 |
| 45 | Hepatosplenomegaly (HP:0001433) | 2.64170684 |
| 46 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.62514674 |
| 47 | Recurrent cutaneous fungal infections (HP:0011370) | 2.62514674 |
| 48 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.58057246 |
| 49 | Abnormality of alanine metabolism (HP:0010916) | 2.58057246 |
| 50 | Hyperalaninemia (HP:0003348) | 2.58057246 |
| 51 | Cellulitis (HP:0100658) | 2.57004915 |
| 52 | Hypergammaglobulinemia (HP:0010702) | 2.56151224 |
| 53 | Retrobulbar optic neuritis (HP:0100654) | 2.55992177 |
| 54 | Optic neuritis (HP:0100653) | 2.55992177 |
| 55 | Progressive neurologic deterioration (HP:0002344) | 2.55657017 |
| 56 | Aplastic anemia (HP:0001915) | 2.53385538 |
| 57 | Abnormality of iron homeostasis (HP:0011031) | 2.50988281 |
| 58 | Oral leukoplakia (HP:0002745) | 2.50462798 |
| 59 | Abnormality of lateral ventricle (HP:0030047) | 2.49534109 |
| 60 | IgM deficiency (HP:0002850) | 2.48908138 |
| 61 | Cerebral palsy (HP:0100021) | 2.48748477 |
| 62 | Type I transferrin isoform profile (HP:0003642) | 2.47286789 |
| 63 | Prolonged partial thromboplastin time (HP:0003645) | 2.46945973 |
| 64 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.45682364 |
| 65 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.42684252 |
| 66 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.42684252 |
| 67 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.42684252 |
| 68 | Panhypogammaglobulinemia (HP:0003139) | 2.40793472 |
| 69 | Abnormality of the anterior horn cell (HP:0006802) | 2.38809794 |
| 70 | Degeneration of anterior horn cells (HP:0002398) | 2.38809794 |
| 71 | Rough bone trabeculation (HP:0100670) | 2.38176044 |
| 72 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.37504763 |
| 73 | Gastrointestinal infarctions (HP:0005244) | 2.37381087 |
| 74 | Abnormal protein glycosylation (HP:0012346) | 2.37224841 |
| 75 | Abnormal glycosylation (HP:0012345) | 2.37224841 |
| 76 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.37224841 |
| 77 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.37224841 |
| 78 | Abnormality of the intrinsic pathway (HP:0010989) | 2.36455591 |
| 79 | Generalized aminoaciduria (HP:0002909) | 2.35416653 |
| 80 | Gingivitis (HP:0000230) | 2.32645774 |
| 81 | Petechiae (HP:0000967) | 2.32034556 |
| 82 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.31223649 |
| 83 | Pustule (HP:0200039) | 2.29631979 |
| 84 | Xanthomatosis (HP:0000991) | 2.29394744 |
| 85 | Abnormality of T cell physiology (HP:0011840) | 2.27871052 |
| 86 | Prolonged bleeding time (HP:0003010) | 2.27824907 |
| 87 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.26944249 |
| 88 | Hyperlipoproteinemia (HP:0010980) | 2.26762698 |
| 89 | Ragged-red muscle fibers (HP:0003200) | 2.26727423 |
| 90 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.25116104 |
| 91 | Hyperammonemia (HP:0001987) | 2.24016731 |
| 92 | Intrahepatic cholestasis (HP:0001406) | 2.23902000 |
| 93 | Vasculitis (HP:0002633) | 2.23387580 |
| 94 | Carpal bone hypoplasia (HP:0001498) | 2.23142245 |
| 95 | Agammaglobulinemia (HP:0004432) | 2.21626948 |
| 96 | Hypoglycemic coma (HP:0001325) | 2.21626340 |
| 97 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.21392624 |
| 98 | Mucopolysacchariduria (HP:0008155) | 2.21392624 |
| 99 | Mutism (HP:0002300) | 2.19990017 |
| 100 | Gastrointestinal inflammation (HP:0004386) | 2.19689866 |
| 101 | Dicarboxylic aciduria (HP:0003215) | 2.16788511 |
| 102 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.16788511 |
| 103 | Megaloblastic anemia (HP:0001889) | 2.15866240 |
| 104 | Increased muscle lipid content (HP:0009058) | 2.15810608 |
| 105 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 2.13755219 |
| 106 | Fat malabsorption (HP:0002630) | 2.10044675 |
| 107 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.08765972 |
| 108 | Chest pain (HP:0100749) | 2.08453625 |
| 109 | Epistaxis (HP:0000421) | 2.08283992 |
| 110 | Abnormality of nucleobase metabolism (HP:0010932) | 2.07322853 |
| 111 | Thrombocytosis (HP:0001894) | 2.05856492 |
| 112 | Systemic lupus erythematosus (HP:0002725) | 2.05038458 |
| 113 | Skin rash (HP:0000988) | 2.04830698 |
| 114 | Leukocytosis (HP:0001974) | 2.03233098 |
| 115 | Deep venous thrombosis (HP:0002625) | 2.02913494 |
| 116 | Amyloidosis (HP:0011034) | 2.02861761 |
| 117 | Inflammation of the large intestine (HP:0002037) | 2.02623128 |
| 118 | Nonimmune hydrops fetalis (HP:0001790) | 1.98273606 |
| 119 | Lymphopenia (HP:0001888) | 1.97763681 |
| 120 | Reticulocytopenia (HP:0001896) | 1.97510086 |
| 121 | Patellar aplasia (HP:0006443) | 1.97121784 |
| 122 | Steatorrhea (HP:0002570) | 1.96963623 |
| 123 | Upper motor neuron abnormality (HP:0002127) | 1.96498627 |
| 124 | Biconcave vertebral bodies (HP:0004586) | 1.93779032 |
| 125 | Sepsis (HP:0100806) | 1.93466791 |
| 126 | Abnormal gallbladder physiology (HP:0012438) | 1.93118968 |
| 127 | Cholecystitis (HP:0001082) | 1.93118968 |
| 128 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.93050071 |
| 129 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.93050071 |
| 130 | Pancytopenia (HP:0001876) | 1.92914779 |
| 131 | Vertebral compression fractures (HP:0002953) | 1.92755701 |
| 132 | Death in infancy (HP:0001522) | 1.92567809 |
| 133 | Nausea (HP:0002018) | 1.92136767 |
| 134 | Abnormality of the common coagulation pathway (HP:0010990) | 1.91955141 |
| 135 | Posterior subcapsular cataract (HP:0007787) | 1.91518190 |
| 136 | Lethargy (HP:0001254) | 1.90763933 |
| 137 | Complement deficiency (HP:0004431) | 1.90403890 |
| 138 | Anorexia (HP:0002039) | 1.89880444 |
| 139 | Colitis (HP:0002583) | 1.89781322 |
| 140 | Seborrheic dermatitis (HP:0001051) | 1.88559680 |
| 141 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.88492305 |
| 142 | Abnormality of T cells (HP:0002843) | 1.88427580 |
| 143 | Spontaneous hematomas (HP:0007420) | 1.88407311 |
| 144 | Severe visual impairment (HP:0001141) | 1.86942725 |
| 145 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.86908339 |
| 146 | 3-Methylglutaconic aciduria (HP:0003535) | 1.85425078 |
| 147 | Brushfield spots (HP:0001088) | 1.85411341 |
| 148 | Hypolipoproteinemia (HP:0010981) | 1.85252347 |
| 149 | Abnormal spermatogenesis (HP:0008669) | 1.84841802 |
| 150 | Bone marrow hypocellularity (HP:0005528) | 1.83869280 |
| 151 | Abnormality of the prostate (HP:0008775) | 1.83482085 |
| 152 | Interstitial pulmonary disease (HP:0006530) | 1.83433400 |
| 153 | Joint hemorrhage (HP:0005261) | 1.83260771 |
| 154 | Episodic fever (HP:0001954) | 1.82792174 |
| 155 | Pulmonary infiltrates (HP:0002113) | 1.82360586 |
| 156 | Neuronal loss in central nervous system (HP:0002529) | 1.82102820 |
| 157 | Hemoptysis (HP:0002105) | 1.82064123 |
| 158 | Prolonged neonatal jaundice (HP:0006579) | 1.81867440 |
| 159 | Progressive muscle weakness (HP:0003323) | 1.81636633 |
| 160 | Abnormality of the pleura (HP:0002103) | 1.81458203 |
| 161 | Impulsivity (HP:0100710) | 1.81121139 |
| 162 | Recurrent pneumonia (HP:0006532) | 1.79787334 |
| 163 | Glomerulonephritis (HP:0000099) | 1.79685122 |
| 164 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.78604712 |
| 165 | Splenomegaly (HP:0001744) | 1.77647004 |
| 166 | IgG deficiency (HP:0004315) | 1.77187075 |
| 167 | Ketosis (HP:0001946) | 1.76560689 |
| 168 | Abnormality of purine metabolism (HP:0004352) | 1.75717624 |
| 169 | Conjugated hyperbilirubinemia (HP:0002908) | 1.74737210 |
| 170 | Abnormal trabecular bone morphology (HP:0100671) | 1.74263650 |
| 171 | Combined immunodeficiency (HP:0005387) | 1.71576659 |
| 172 | Multiple enchondromatosis (HP:0005701) | 1.67965213 |
| 173 | Entropion (HP:0000621) | 1.67477204 |
| 174 | Sparse eyelashes (HP:0000653) | 1.66145564 |
| 175 | Neutropenia (HP:0001875) | 1.65818455 |
| 176 | Granulocytopenia (HP:0001913) | 1.65368438 |
| 177 | Abnormal number of erythroid precursors (HP:0012131) | 1.64829759 |
| 178 | Myocardial infarction (HP:0001658) | 1.64570324 |
| 179 | Poor head control (HP:0002421) | 1.64458483 |
| 180 | Encephalitis (HP:0002383) | 1.63948133 |
| 181 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.63274968 |
| 182 | Periodontitis (HP:0000704) | 1.63205416 |
| 183 | Severe combined immunodeficiency (HP:0004430) | 1.62812490 |
| 184 | Autoimmune thrombocytopenia (HP:0001973) | 1.62170042 |
| 185 | Abnormality of methionine metabolism (HP:0010901) | 1.61861623 |
| 186 | Increased serum lactate (HP:0002151) | 1.59924344 |
| 187 | Hyperbilirubinemia (HP:0002904) | 1.58861623 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BUB1 | 4.11355237 |
| 2 | BCKDK | 3.65102886 |
| 3 | MAP3K11 | 3.14643009 |
| 4 | NME2 | 3.06310637 |
| 5 | RIPK4 | 2.95760142 |
| 6 | STK16 | 2.92086420 |
| 7 | WEE1 | 2.77953420 |
| 8 | IRAK3 | 2.39192294 |
| 9 | TAOK3 | 2.37580554 |
| 10 | EIF2AK1 | 2.26606062 |
| 11 | ERN1 | 2.25316098 |
| 12 | TESK1 | 2.25016547 |
| 13 | PLK4 | 2.09489753 |
| 14 | EIF2AK3 | 2.09323014 |
| 15 | NEK2 | 2.08203814 |
| 16 | EPHA2 | 2.01722690 |
| 17 | TNK2 | 2.00030491 |
| 18 | MAP4K1 | 1.91754644 |
| 19 | PRPF4B | 1.86792188 |
| 20 | PASK | 1.84207689 |
| 21 | ZAP70 | 1.82164254 |
| 22 | FES | 1.80460063 |
| 23 | BRAF | 1.74039010 |
| 24 | CDK19 | 1.73927014 |
| 25 | TSSK6 | 1.62283555 |
| 26 | KDR | 1.61225738 |
| 27 | AKT3 | 1.59426136 |
| 28 | BRSK2 | 1.57423229 |
| 29 | FLT3 | 1.56482258 |
| 30 | TAOK1 | 1.54443215 |
| 31 | MAP2K2 | 1.54389795 |
| 32 | PIM2 | 1.52861662 |
| 33 | SRPK1 | 1.51500273 |
| 34 | MAP2K3 | 1.48592933 |
| 35 | SMG1 | 1.45339556 |
| 36 | RPS6KA4 | 1.42732909 |
| 37 | CSK | 1.42229079 |
| 38 | BTK | 1.37803953 |
| 39 | TYK2 | 1.36143754 |
| 40 | VRK2 | 1.31564606 |
| 41 | TXK | 1.30586777 |
| 42 | TESK2 | 1.28471315 |
| 43 | TEC | 1.27552701 |
| 44 | SIK3 | 1.27339027 |
| 45 | IRAK4 | 1.23209286 |
| 46 | BLK | 1.23185373 |
| 47 | DYRK3 | 1.21044669 |
| 48 | CDK7 | 1.18929107 |
| 49 | DYRK1B | 1.18124350 |
| 50 | ZAK | 1.15969870 |
| 51 | CCNB1 | 1.14596448 |
| 52 | PLK1 | 1.14271024 |
| 53 | ACVR1B | 1.13236131 |
| 54 | MAP3K1 | 1.10542361 |
| 55 | TTK | 1.08435655 |
| 56 | FGFR4 | 1.07629873 |
| 57 | AURKB | 1.06598784 |
| 58 | MATK | 1.03287557 |
| 59 | SIK2 | 1.02528961 |
| 60 | CDK4 | 0.99044815 |
| 61 | MAP3K13 | 0.98580112 |
| 62 | HCK | 0.96952573 |
| 63 | MAP4K2 | 0.93650989 |
| 64 | VRK1 | 0.92470503 |
| 65 | TBK1 | 0.92037220 |
| 66 | NME1 | 0.91419296 |
| 67 | MAP3K14 | 0.90627154 |
| 68 | EPHB1 | 0.89685865 |
| 69 | PAK4 | 0.89386841 |
| 70 | JAK3 | 0.88437303 |
| 71 | KSR2 | 0.87396058 |
| 72 | PKN2 | 0.85605235 |
| 73 | FGR | 0.84852851 |
| 74 | MARK2 | 0.84072377 |
| 75 | MKNK1 | 0.82853816 |
| 76 | TAOK2 | 0.82825560 |
| 77 | STK38L | 0.82789775 |
| 78 | IRAK2 | 0.82522770 |
| 79 | EIF2AK2 | 0.82361195 |
| 80 | LRRK2 | 0.81574954 |
| 81 | BRSK1 | 0.80537895 |
| 82 | ATR | 0.80366923 |
| 83 | MAP3K8 | 0.79963062 |
| 84 | PLK3 | 0.79301084 |
| 85 | PIM1 | 0.78926987 |
| 86 | MAP3K12 | 0.78208040 |
| 87 | PRKCI | 0.76119107 |
| 88 | MAPK11 | 0.75545781 |
| 89 | JAK2 | 0.75375775 |
| 90 | LCK | 0.74895852 |
| 91 | IKBKB | 0.74376766 |
| 92 | ITK | 0.74009576 |
| 93 | KIT | 0.72928616 |
| 94 | RPS6KB2 | 0.72503134 |
| 95 | SCYL2 | 0.71391715 |
| 96 | PRKD2 | 0.70710807 |
| 97 | CHUK | 0.69762247 |
| 98 | MARK3 | 0.69751783 |
| 99 | RAF1 | 0.67271234 |
| 100 | CDC7 | 0.66193552 |
| 101 | CDK8 | 0.64674670 |
| 102 | MAP2K6 | 0.63849126 |
| 103 | AURKA | 0.61970695 |
| 104 | IKBKE | 0.61254538 |
| 105 | MAP3K10 | 0.60844133 |
| 106 | MKNK2 | 0.60627102 |
| 107 | DAPK1 | 0.60436387 |
| 108 | INSRR | 0.60314839 |
| 109 | MAP3K3 | 0.59554348 |
| 110 | CDK3 | 0.59549383 |
| 111 | MAP2K7 | 0.59376835 |
| 112 | ARAF | 0.59194490 |
| 113 | NLK | 0.58339257 |
| 114 | SIK1 | 0.58172385 |
| 115 | GRK6 | 0.57205120 |
| 116 | MAP2K4 | 0.57071323 |
| 117 | STK10 | 0.57019741 |
| 118 | SYK | 0.54762246 |
| 119 | CHEK2 | 0.53382084 |
| 120 | IRAK1 | 0.53207080 |
| 121 | WNK3 | 0.52753692 |
| 122 | TIE1 | 0.52557712 |
| 123 | LYN | 0.50746301 |
| 124 | EEF2K | 0.50181999 |
| 125 | MAP3K5 | 0.49576328 |
| 126 | RPS6KL1 | 0.49176085 |
| 127 | RPS6KC1 | 0.49176085 |
| 128 | TLK1 | 0.48183334 |
| 129 | TRIB3 | 0.47746982 |
| 130 | TGFBR1 | 0.47129896 |
| 131 | RPS6KA5 | 0.47044419 |
| 132 | NEK9 | 0.46938396 |
| 133 | ABL2 | 0.46251734 |
| 134 | PAK1 | 0.42611190 |
| 135 | CSNK2A1 | 0.41570974 |
| 136 | PINK1 | 0.41295443 |
| 137 | PIK3CG | 0.41079245 |
| 138 | PRKCQ | 0.40911927 |
| 139 | PDPK1 | 0.40798634 |
| 140 | CAMK4 | 0.40331186 |
| 141 | PDK1 | 0.38829495 |
| 142 | CSF1R | 0.38560685 |
| 143 | PTK6 | 0.37964375 |
| 144 | GRK7 | 0.37928313 |
| 145 | DYRK2 | 0.37085571 |
| 146 | LIMK1 | 0.36423552 |
| 147 | MOS | 0.35264967 |
| 148 | RPS6KA6 | 0.35095941 |
| 149 | RPS6KA2 | 0.34795196 |
| 150 | MAP3K6 | 0.33170058 |
| 151 | BMX | 0.30486907 |
| 152 | FYN | 0.30296185 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.91592086 |
| 2 | Allograft rejection_Homo sapiens_hsa05330 | 2.79869899 |
| 3 | DNA replication_Homo sapiens_hsa03030 | 2.70757139 |
| 4 | RNA polymerase_Homo sapiens_hsa03020 | 2.61700104 |
| 5 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.56989393 |
| 6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.55370740 |
| 7 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.51070078 |
| 8 | Asthma_Homo sapiens_hsa05310 | 2.50092201 |
| 9 | Proteasome_Homo sapiens_hsa03050 | 2.37216024 |
| 10 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.32055946 |
| 11 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.31175964 |
| 12 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.23911208 |
| 13 | Mismatch repair_Homo sapiens_hsa03430 | 2.14272978 |
| 14 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.13403948 |
| 15 | Base excision repair_Homo sapiens_hsa03410 | 2.05535512 |
| 16 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.02988453 |
| 17 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.99354339 |
| 18 | Sulfur relay system_Homo sapiens_hsa04122 | 1.93410877 |
| 19 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.92501711 |
| 20 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.90268315 |
| 21 | Tuberculosis_Homo sapiens_hsa05152 | 1.89705279 |
| 22 | Ribosome_Homo sapiens_hsa03010 | 1.89345203 |
| 23 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.86936419 |
| 24 | Protein export_Homo sapiens_hsa03060 | 1.86879361 |
| 25 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.79028818 |
| 26 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.74255021 |
| 27 | Viral myocarditis_Homo sapiens_hsa05416 | 1.70767361 |
| 28 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.68136850 |
| 29 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.67326564 |
| 30 | Phagosome_Homo sapiens_hsa04145 | 1.66480819 |
| 31 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.65905541 |
| 32 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.64309328 |
| 33 | RNA transport_Homo sapiens_hsa03013 | 1.61965728 |
| 34 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.61826606 |
| 35 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.60181170 |
| 36 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.59296264 |
| 37 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.57501450 |
| 38 | Homologous recombination_Homo sapiens_hsa03440 | 1.51258260 |
| 39 | Shigellosis_Homo sapiens_hsa05131 | 1.51097586 |
| 40 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.49440259 |
| 41 | Spliceosome_Homo sapiens_hsa03040 | 1.47755511 |
| 42 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.47346364 |
| 43 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.43030168 |
| 44 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.41536010 |
| 45 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.40953703 |
| 46 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.39554494 |
| 47 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.38933394 |
| 48 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.38161669 |
| 49 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.36123960 |
| 50 | Cell cycle_Homo sapiens_hsa04110 | 1.36055610 |
| 51 | Salmonella infection_Homo sapiens_hsa05132 | 1.33615936 |
| 52 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.32475117 |
| 53 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.25687590 |
| 54 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.25418114 |
| 55 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.23050747 |
| 56 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.22113839 |
| 57 | Malaria_Homo sapiens_hsa05144 | 1.21248781 |
| 58 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.16124590 |
| 59 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.15623276 |
| 60 | Purine metabolism_Homo sapiens_hsa00230 | 1.15224674 |
| 61 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.15136256 |
| 62 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.12566823 |
| 63 | Other glycan degradation_Homo sapiens_hsa00511 | 1.12017376 |
| 64 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.09153237 |
| 65 | Peroxisome_Homo sapiens_hsa04146 | 1.08299437 |
| 66 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.07799606 |
| 67 | Galactose metabolism_Homo sapiens_hsa00052 | 1.07683534 |
| 68 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.07024609 |
| 69 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.06677295 |
| 70 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.03862879 |
| 71 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.03565701 |
| 72 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.01390419 |
| 73 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.00647905 |
| 74 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.98280004 |
| 75 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.96378050 |
| 76 | Pertussis_Homo sapiens_hsa05133 | 0.96197787 |
| 77 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.95613414 |
| 78 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.95335038 |
| 79 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.94669938 |
| 80 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.94016291 |
| 81 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.93072829 |
| 82 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.92895524 |
| 83 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.92030930 |
| 84 | Basal transcription factors_Homo sapiens_hsa03022 | 0.91777593 |
| 85 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.91291513 |
| 86 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.91129656 |
| 87 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.90963625 |
| 88 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.90805336 |
| 89 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.90756627 |
| 90 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.90085851 |
| 91 | Parkinsons disease_Homo sapiens_hsa05012 | 0.87074561 |
| 92 | Carbon metabolism_Homo sapiens_hsa01200 | 0.86731273 |
| 93 | Legionellosis_Homo sapiens_hsa05134 | 0.85734653 |
| 94 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.84253028 |
| 95 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.83615910 |
| 96 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.83148572 |
| 97 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.82649783 |
| 98 | Hepatitis B_Homo sapiens_hsa05161 | 0.81298968 |
| 99 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.80637069 |
| 100 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.80378462 |
| 101 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.79546831 |
| 102 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.78627923 |
| 103 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.78568094 |
| 104 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.78056748 |
| 105 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.77987507 |
| 106 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.75308174 |
| 107 | Lysosome_Homo sapiens_hsa04142 | 0.74259945 |
| 108 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.74039052 |
| 109 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.73185092 |
| 110 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.73136397 |
| 111 | Endocytosis_Homo sapiens_hsa04144 | 0.72693988 |
| 112 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.71703347 |
| 113 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.71350411 |
| 114 | Retinol metabolism_Homo sapiens_hsa00830 | 0.71256181 |
| 115 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.69717288 |
| 116 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.67611159 |
| 117 | RNA degradation_Homo sapiens_hsa03018 | 0.66315901 |
| 118 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.65470773 |
| 119 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.65365428 |
| 120 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.64508797 |
| 121 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.64361656 |
| 122 | Metabolic pathways_Homo sapiens_hsa01100 | 0.64040400 |
| 123 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.63527846 |
| 124 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.63235711 |
| 125 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.62593900 |
| 126 | Hepatitis C_Homo sapiens_hsa05160 | 0.61955381 |
| 127 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.61877527 |
| 128 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.61551540 |
| 129 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.60203311 |
| 130 | HTLV-I infection_Homo sapiens_hsa05166 | 0.59239001 |
| 131 | Histidine metabolism_Homo sapiens_hsa00340 | 0.58455790 |
| 132 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.57852424 |
| 133 | Bladder cancer_Homo sapiens_hsa05219 | 0.57833727 |
| 134 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.57330249 |
| 135 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.57052311 |
| 136 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.54592943 |
| 137 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.52655589 |
| 138 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.51459853 |
| 139 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.51309592 |
| 140 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.51246371 |
| 141 | Measles_Homo sapiens_hsa05162 | 0.50981069 |
| 142 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.49024484 |
| 143 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.48368282 |
| 144 | Huntingtons disease_Homo sapiens_hsa05016 | 0.47275365 |
| 145 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.47203755 |
| 146 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.43184877 |
| 147 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.42658041 |
| 148 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.42382046 |
| 149 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.40875700 |
| 150 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.40796043 |
| 151 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.40668979 |
| 152 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.38660196 |
| 153 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.37974850 |
| 154 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.37673616 |
| 155 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.37427862 |
| 156 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.36841390 |
| 157 | Apoptosis_Homo sapiens_hsa04210 | 0.35221313 |
| 158 | ABC transporters_Homo sapiens_hsa02010 | 0.34954921 |
| 159 | Influenza A_Homo sapiens_hsa05164 | 0.34788884 |
| 160 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.34326068 |
| 161 | Platelet activation_Homo sapiens_hsa04611 | 0.33994536 |
| 162 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.33436154 |
| 163 | Leishmaniasis_Homo sapiens_hsa05140 | 0.32673911 |
| 164 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.32492491 |
| 165 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.31312085 |

